Rosemary C. She
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rosemary C. She has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Cathy A. Petti
10 shared publicationsEdward W. Taggart
5 shared publications- Christine M. Litwin
Department of Pathology, Medical College of Georgia, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USA
4 shared publications Weston C. Hymas
4 shared publicationsAmit R. Phansalkar
Department of Pathology, University of Utah, 30 North 1900 East, Salt Lake City, Utah 84132,1 Associated Regional University Pathologists Institute for Research and Development, 500 Chipeta Way, Salt Lake City, Utah 84108,2 Department of Medicine, University of Utah, Salt Lake City, Utah3
2 shared publications- Andrew R. Wilson
Department of Family and Preventive Medicine, University of Utah, Salt Lake City, Utah, United States of America
2 shared publications
Latest Publications
- 1 January 2011
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 25 (4) , 305-308
Correlation of Chlamydia and Chlamydophila spp. IgG and IgM antibodies by microimmunofluorescence with antigen detection methods
Correlation of serologic titers for Chlamydia trachomatis with other tests has been based on direct fluorescence antibody (DFA) testing and culture, but not on nucleic acid‐based tests that are used for screening. We retrospectively reviewed the specificity of antibodies against C. trachomatis, Chlamydia psittaci, and Chlamydophila pneumoniae by microimmunofluorescence (MIF) when compared with DFA, culture, nucleic acid probe, and transcription‐mediated amplification. Over a 6‐year period, 226 cases had both MIF and one of these other methods performed for comparison. Agreement between C. trachomatis antigen or nucleic acid detection and MIF results was 87% (197/226). C. trachomatis serology had a negative predictive value of 98%, and 10.6% of cases were positive by serology and negative by antigen testing. Of the 13 patients who had a positive C. trachomatis antigen or nucleic acid test result, 9 had IgG and/or IgM titers highest against C. trachomatis, 3 had IgG titers highest against C. pneumoniae, and 1 had undetectable titers for the three chlamydial species. Twenty‐five patients had positive IgG and/or IgM titers to C. trachomatis but negative antigen test results. Serologic testing can increase the sensitivity of detecting C. trachomatis infections. J. Clin. Lab. Anal. 25:305–308, 2011.
- 1 January 2011
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 25 (4) , 305-308
Correlation of Chlamydia and Chlamydophila spp. IgG and IgM antibodies by microimmunofluorescence with antigen detection methods
Correlation of serologic titers for Chlamydia trachomatis with other tests has been based on direct fluorescence antibody (DFA) testing and culture, but not on nucleic acid‐based tests that are used for screening. We retrospectively reviewed the specificity of antibodies against C. trachomatis, Chlamydia psittaci, and Chlamydophila pneumoniae by microimmunofluorescence (MIF) when compared with DFA, culture, nucleic acid probe, and transcription‐mediated amplification. Over a 6‐year period, 226 cases had both MIF and one of these other methods performed for comparison. Agreement between C. trachomatis antigen or nucleic acid detection and MIF results was 87% (197/226). C. trachomatis serology had a negative predictive value of 98%, and 10.6% of cases were positive by serology and negative by antigen testing. Of the 13 patients who had a positive C. trachomatis antigen or nucleic acid test result, 9 had IgG and/or IgM titers highest against C. trachomatis, 3 had IgG titers highest against C. pneumoniae, and 1 had undetectable titers for the three chlamydial species. Twenty‐five patients had positive IgG and/or IgM titers to C. trachomatis but negative antigen test results. Serologic testing can increase the sensitivity of detecting C. trachomatis infections. J. Clin. Lab. Anal. 25:305–308, 2011.
- 1 January 2011
- Published by American Society for Microbiology
- p. 479-489
Identification of Bacteria by DNA Target Sequencing in a Clinical Microbiology Laboratory
- 1 January 2011
- Published by American Society for Microbiology
- p. 479-489
Identification of Bacteria by DNA Target Sequencing in a Clinical Microbiology Laboratory
- 1 October 2010
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 29 (10) , 970-972
IDENTIFYING RESPIRATORY VIRUSES IN NASAL MUCUS FROM CHILDREN
Large amounts of respiratory viruses are shed in nasal secretions by children. Nasal mucus was compared with nasopharyngeal swabs as a source for respiratory virus testing. Multiplex reverse transcription-polymerase chain reaction detected virus in nasal mucus specimens in 73% (11/15) of positive cases, demonstrating the potential utility of less invasive specimens when a highly sensitive method is used for respiratory virus detection.
- 1 October 2010
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 29 (10) , 970-972
IDENTIFYING RESPIRATORY VIRUSES IN NASAL MUCUS FROM CHILDREN
Large amounts of respiratory viruses are shed in nasal secretions by children. Nasal mucus was compared with nasopharyngeal swabs as a source for respiratory virus testing. Multiplex reverse transcription-polymerase chain reaction detected virus in nasal mucus specimens in 73% (11/15) of positive cases, demonstrating the potential utility of less invasive specimens when a highly sensitive method is used for respiratory virus detection.
- 1 September 2010
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (9) , 3380-3382
Limited Utility of Culture for Mycoplasma pneumoniae and Chlamydophila pneumoniae for Diagnosis of Respiratory Tract Infections
We assessed the utility of culture for Mycoplasma pneumoniae and Chlamydophila pneumoniae to diagnose respiratory tract infections. Compared to PCR and IgM serology, culture was less sensitive and had extremely low yield. Culture is not recommended for these pathogens, and this method should be eliminated from routine practice.
- 1 September 2010
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (9) , 3380-3382
Limited Utility of Culture for Mycoplasma pneumoniae and Chlamydophila pneumoniae for Diagnosis of Respiratory Tract Infections
We assessed the utility of culture for Mycoplasma pneumoniae and Chlamydophila pneumoniae to diagnose respiratory tract infections. Compared to PCR and IgM serology, culture was less sensitive and had extremely low yield. Culture is not recommended for these pathogens, and this method should be eliminated from routine practice.
- 1 August 2010
- Published by Wiley in Archives of Pathology & Laboratory Medicine
- Vol. 134 (8) , 1177-80
Comparison of 10 indirect fluorescent antibodies to detect and type influenza A specimens.
Management of influenza infections relies on rapid, accurate, and sensitive diagnostic techniques. Influenza A (IA) strain typing has become more important since the emergence of highly pathogenic avian and novel influenza strains and the high frequency of oseltamivir resistance in circulating H1N1 isolates. To analyze the performance of indirect fluorescent antibody testing for subtyping a broad range of IA strains. Ten indirect fluorescent antibody reagents were used to detect and type 100 archived IA respiratory specimens from 1986 through 1995 and 2006 through 2007 and a reassortant, nonpathogenic H5N1 sample. Both direct specimen and cultured isolates were tested. Reverse transcription-polymerase chain reaction was used to confirm indirect fluorescent antibody results. Three H1N1-, 2 H3N2-, and 1 H1-H2-H3-H5-specific antibodies (Chemicon Diagnostics), an IA pool reagent (Trinity Biotech), and H1, H3, and H1-H3-specific antibodies (Centers for Disease Control and Prevention) were used. Reverse transcription-polymerase chain reaction confirmed all 100 isolates as IA and identified 71 as H1, 22 as H3, and 7 as non-H1-H3. Sensitivity of direct specimen testing ranged was 18.3% to 57.7% for the H1 reagents, 36.4% to 50.0% for the H3 reagents, and 40.0% to 53.8% for the pool reagents. Subtyping was more sensitive on cultured isolates than direct specimens. Specificity for all antibodies was 89.7% to 100%. The H5N1 sample was positive by direct testing and culture (reverse transcription-polymerase chain reaction, Centers for Disease Control and Prevention H5N1 pool, Chemicon H1-H2-H3-H5). No cross-reactivity was observed when the 10 antibodies were tested against other common respiratory viruses. When positive, IA subtyping antibodies can serve as a useful diagnostic tool when multiple influenza virus subtypes are cocirculating with different susceptibility patterns.
- 1 August 2010
- Published by Wiley in Archives of Pathology & Laboratory Medicine
- Vol. 134 (8) , 1177-80
Comparison of 10 indirect fluorescent antibodies to detect and type influenza A specimens.
Management of influenza infections relies on rapid, accurate, and sensitive diagnostic techniques. Influenza A (IA) strain typing has become more important since the emergence of highly pathogenic avian and novel influenza strains and the high frequency of oseltamivir resistance in circulating H1N1 isolates. To analyze the performance of indirect fluorescent antibody testing for subtyping a broad range of IA strains. Ten indirect fluorescent antibody reagents were used to detect and type 100 archived IA respiratory specimens from 1986 through 1995 and 2006 through 2007 and a reassortant, nonpathogenic H5N1 sample. Both direct specimen and cultured isolates were tested. Reverse transcription-polymerase chain reaction was used to confirm indirect fluorescent antibody results. Three H1N1-, 2 H3N2-, and 1 H1-H2-H3-H5-specific antibodies (Chemicon Diagnostics), an IA pool reagent (Trinity Biotech), and H1, H3, and H1-H3-specific antibodies (Centers for Disease Control and Prevention) were used. Reverse transcription-polymerase chain reaction confirmed all 100 isolates as IA and identified 71 as H1, 22 as H3, and 7 as non-H1-H3. Sensitivity of direct specimen testing ranged was 18.3% to 57.7% for the H1 reagents, 36.4% to 50.0% for the H3 reagents, and 40.0% to 53.8% for the pool reagents. Subtyping was more sensitive on cultured isolates than direct specimens. Specificity for all antibodies was 89.7% to 100%. The H5N1 sample was positive by direct testing and culture (reverse transcription-polymerase chain reaction, Centers for Disease Control and Prevention H5N1 pool, Chemicon H1-H2-H3-H5). No cross-reactivity was observed when the 10 antibodies were tested against other common respiratory viruses. When positive, IA subtyping antibodies can serve as a useful diagnostic tool when multiple influenza virus subtypes are cocirculating with different susceptibility patterns.
- Open Access
- 1 August 2010
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 134 (8) , 1177-1180
Comparison of 10 Indirect Fluorescent Antibodies to Detect and Type Influenza A Specimens
Context. —Management of influenza infections relies on rapid, accurate, and sensitive diagnostic techniques. Influenza A (IA) strain typing has become more important since the emergence of highly pathogenic avian and novel influenza strains and the high frequency of oseltamivir resistance in circulating H1N1 isolates. Objective. —To analyze the performance of indirect fluorescent antibody testing for subtyping a broad range of IA strains. Design. —Ten indirect fluorescent antibody reagents were used to detect and type 100 archived IA respiratory specimens from 1986 through 1995 and 2006 through 2007 and a reassortant, nonpathogenic H5N1 sample. Both direct specimen and cultured isolates were tested. Reverse transcription-polymerase chain reaction was used to confirm indirect fluorescent antibody results. Three H1N1-, 2 H3N2-, and 1 H1-H2-H3-H5–specific antibodies (Chemicon Diagnostics), an IA pool reagent (Trinity Biotech), and H1, H3, and H1-H3–specific antibodies (Centers for Disease Control and Prevention) were used. Results. —Reverse transcription-polymerase chain reaction confirmed all 100 isolates as IA and identified 71 as H1, 22 as H3, and 7 as non–H1-H3. Sensitivity of direct specimen testing ranged was 18.3% to 57.7% for the H1 reagents, 36.4% to 50.0% for the H3 reagents, and 40.0% to 53.8% for the pool reagents. Subtyping was more sensitive on cultured isolates than direct specimens. Specificity for all antibodies was 89.7% to 100%. The H5N1 sample was positive by direct testing and culture (reverse transcription-polymerase chain reaction, Centers for Disease Control and Prevention H5N1 pool, Chemicon H1-H2-H3-H5). No cross-reactivity was observed when the 10 antibodies were tested against other common respiratory viruses. Conclusions. —When positive, IA subtyping antibodies can serve as a useful diagnostic tool when multiple influenza virus subtypes are cocirculating with different susceptibility patterns.
- 1 August 2010
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 134 (8) , 1177-1180
Open AccessComparison of 10 Indirect Fluorescent Antibodies to Detect and Type Influenza A Specimens
Context. —Management of influenza infections relies on rapid, accurate, and sensitive diagnostic techniques. Influenza A (IA) strain typing has become more important since the emergence of highly pathogenic avian and novel influenza strains and the high frequency of oseltamivir resistance in circulating H1N1 isolates. Objective. —To analyze the performance of indirect fluorescent antibody testing for subtyping a broad range of IA strains. Design. —Ten indirect fluorescent antibody reagents were used to detect and type 100 archived IA respiratory specimens from 1986 through 1995 and 2006 through 2007 and a reassortant, nonpathogenic H5N1 sample. Both direct specimen and cultured isolates were tested. Reverse transcription-polymerase chain reaction was used to confirm indirect fluorescent antibody results. Three H1N1-, 2 H3N2-, and 1 H1-H2-H3-H5–specific antibodies (Chemicon Diagnostics), an IA pool reagent (Trinity Biotech), and H1, H3, and H1-H3–specific antibodies (Centers for Disease Control and Prevention) were used. Results. —Reverse transcription-polymerase chain reaction confirmed all 100 isolates as IA and identified 71 as H1, 22 as H3, and 7 as non–H1-H3. Sensitivity of direct specimen testing ranged was 18.3% to 57.7% for the H1 reagents, 36.4% to 50.0% for the H3 reagents, and 40.0% to 53.8% for the pool reagents. Subtyping was more sensitive on cultured isolates than direct specimens. Specificity for all antibodies was 89.7% to 100%. The H5N1 sample was positive by direct testing and culture (reverse transcription-polymerase chain reaction, Centers for Disease Control and Prevention H5N1 pool, Chemicon H1-H2-H3-H5). No cross-reactivity was observed when the 10 antibodies were tested against other common respiratory viruses. Conclusions. —When positive, IA subtyping antibodies can serve as a useful diagnostic tool when multiple influenza virus subtypes are cocirculating with different susceptibility patterns.
- 1 July 2010
- Published by Elsevier in Cardiovascular Pathology
- Vol. 19 (4) , e99-e105
Utility of immunofluorescence and electron microscopy in endomyocardial biopsies from patients with unexplained heart failure
- 1 July 2010
- Published by Elsevier in Cardiovascular Pathology
- Vol. 19 (4) , e99-e105
Utility of immunofluorescence and electron microscopy in endomyocardial biopsies from patients with unexplained heart failure
- 1 July 2010
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 67 (3) , 246-250
Performance of diagnostic tests to detect respiratory viruses in older adults
- 1 July 2010
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 67 (3) , 246-250
Performance of diagnostic tests to detect respiratory viruses in older adults
- 1 April 2010
- Published by Elsevier in Journal of Virological Methods
- Vol. 165 (1) , 46-50
Performance of enterovirus genotyping targeting the VP1 and VP2 regions on non-typeable isolates and patient specimens
- 1 April 2010
- Published by Elsevier in Journal of Virological Methods
- Vol. 165 (1) , 46-50
Performance of enterovirus genotyping targeting the VP1 and VP2 regions on non-typeable isolates and patient specimens
- 1 March 2010
- Published by Taylor & Francis
- p. 197-209
Laboratory Diagnosis of Viruses in Resource-Limited Settings
- 1 March 2010
- Published by Taylor & Francis
- p. 197-209
Laboratory Diagnosis of Viruses in Resource-Limited Settings